MIA, MIA2, and TANGO overexpression was detected in 33.3% (22/66), 30.3% (20/66), and 27.3% (18/66) of ESCC cases, respectively (Figure 2A–2C). This evidence concerns the gene MIA3 and esophageal squamous cell carcinoma.